Molbio Diagnostics Share Price Falls Over 8% After Two-Day Sell-Off
Add Preferred News Source
Molbio Diagnostics shares fell 8.8% on 16 September, extending their decline to 18.5% over two sessions. Despite the correction, the stock remains more than 50% above its ₹807 IPO price
Molbio Diagnostics shares came under pressure on Wednesday, 16 September, with the recently listed stock falling nearly 9% during the session.
The shares touched an intraday low of ₹1,229.65 on the Bombay Stock Exchange (BSE), down 8.8% from the previous close. This was the second straight session of decline for the stock, even as the broader market traded higher.
Molbio Diagnostics stock had gained around 13% in the week before the latest fall. After Wednesday's decline, the stock was down about 18.5% over the past two sessions.
Stock Still Up Over 50% From IPO Price
Despite the recent correction, the Molbio Diagnostics share price remains well above its IPO price of ₹807.
The company listed on 17 August at ₹980 a share, giving investors a 21.44% premium over the issue price. The stock went on to climb further and hit a 52-week high of ₹1,686.50 on 11 September. Its 52-week low of ₹925.80 was recorded on the listing day.
Even after the latest fall, the stock has gained around 75% over the past month, showing how sharply it had moved before the recent profit booking.
Strong Q1FY27 Performance
Molbio Diagnostics had reported a sharp improvement in its financial performance for the April-June quarter of FY27.
Consolidated net profit attributable to owners stood at ₹58.74 crore, compared with a net loss of ₹23.74 crore in the same quarter last year.
Revenue from operations rose 309% year-on-year to ₹408 crore from ₹100 crore. The company also reported a positive operational earnings before interest, tax, depreciation and amortisation (EBITDA) of ₹101 crore for the quarter.
Also Read - Glass Wall Systems IPO Listing: Shares List At 7% Premium On NSE
This article is for informational purposes only and should not be considered investment advice from Kotak Neo. For compliance T&C and disclaimers, Visit www.kotakneo.com/disclaimer
Vishwa has spent 10+ years across fintech and FMCG doing what most people miss, connecting the dots, catching trends before they trend, and finding the angle nobody else thought to ask about.
At Kotak Neo, she drives content strategy for neoshorts, Kotak News Desk, and Investing Guide, turning market noise into something worth reading.
When she's not decoding markets, she trades charts for canvases, chasing art, painting, and architecture across cities she's yet to explore.
Right Tools, Rich Insights
